Cart
sales@molnova.com
Imitrodast
CAS No. 114686-12-3
Imitrodast( —— )
Catalog No. M36182 CAS No. 114686-12-3
Imitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 215 | In Stock |
|
| 10MG | 311 | In Stock |
|
| 25MG | 471 | In Stock |
|
| 50MG | 643 | In Stock |
|
| 100MG | 879 | In Stock |
|
| 200MG | 1190 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameImitrodast
-
NoteResearch use only, not for human use.
-
Brief DescriptionImitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
-
DescriptionImitrodast is a small molecule thromboxane A2 synthase (TXA2 synthase) inhibitor for the treatment of immune system disorders, respiratory disorders, and cardiovascular diseases, and can be used in studies of arterial thrombosis, asthma, and coronary vasospasm.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114686-12-3
-
Formula Weight260.31
-
Molecular FormulaC13H12N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1SC2=C(C1)CCC(C(O)=O)=C2)N3C=CN=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Etamsylate
Ethamsylate is a haemostatic drug, which inhibits biosynthesis and action of prostaglandins, and increases capillary endothelial resistance as and platelet adhesion.
-
AZD-8165
AZD-8165 is a potent, selective and oral thrombin inhibitor for treatment of thrombosis.
-
Ozagrel
Ozagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet.
